[This corrects the article DOI: 10.18632/oncotarget.22876.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231455 | PMC |
| http://dx.doi.org/10.18632/oncotarget.26283 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study.
Clin Epigenetics
July 2024
Department of Molecular and Translational Medicine, Biology and Genetic Division, University of Brescia, Viale Europa, 11, 25123, Brescia, Italy.
Background: Electroconvulsive therapy (ECT) benefits patients with treatment-resistant depression (TRD), but the underlying biological processes are unclear. We conducted an epigenome-wide association study in 32 TRD patients undergoing ECT to depict ECT-associated methylation changes. Illness severity and ECT outcomes were assessed with the Montgomery-Åsberg Depression Rating Scale at baseline (T0) and 1 month after its end (T1).
View Article and Find Full Text PDFThe protective roles of NLRP6 in intestinal epithelial cells.
Cell Prolif
March 2019
Department of General Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
The evolution of chronic inflammatory diseases is thought to be due to a combination of host genetic variations and environmental factors that include the alteration of intestinal flora, termed "dysbiosis." The intestinal mucosal barrier includes a chemical barrier and physical barrier that have important roles in protecting the intestine against inflammatory injury. The chemical barrier includes antimicrobial peptides (AMPs), and the physical barrier includes a mucous layer, a monolayer of intestinal epithelial cells and cell junctions.
View Article and Find Full Text PDFCorrection: NLRP6 targeting suppresses gastric tumorigenesis via P14-Mdm2-P53-dependent cellular senescence.
Oncotarget
October 2018
Department of Gastrointestinal Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian, China.
[This corrects the article DOI: 10.18632/oncotarget.22876.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!